Colloid
PreclinicalSmall molecule
Colloid is one of 12 small molecule programs targeting Hemodynamic. It is currently in Preclinical.
2
Indications
5
Total Trials
0
Active Trials
11
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
9 competitors in Kidney Injury
#DrugCompanyPhaseTrials
1Ketalar
AAultman Health Foundation
Approved
Cysteine Hydrochloride
NovartisPhase 3
Ultiva
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Aminoglycoside
PfizerPreclinical
Crystalloid
KKonkuk University Medical Center
Preclinical
Colloid
SSahlgrenska University Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Postoperative Morbidity1 trial
Kidney Injury1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Colloid. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SSahlgrenska University Hospital